Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Thermal Ablation for Intrahepatic Cholangiocarcinoma in Cirrhosis: Safety and Efficacy in Non-Surgical Patients.

Díaz-González Á, Vilana R, Bianchi L, García-Criado Á, Rimola J, Rodríguez de Lope C, Ferrer J, Ayuso C, Da Fonseca LG, Reig M, Forner A.

J Vasc Interv Radiol. 2019 Nov 1. pii: S1051-0443(19)30576-7. doi: 10.1016/j.jvir.2019.06.014. [Epub ahead of print]

PMID:
31685360
2.

Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.

Rimola J, Forner A, Sapena V, Llarch N, Darnell A, Díaz A, García-Criado A, Bianchi L, Vilana R, Díaz-González Á, Ayuso C, Bruix J, Reig M.

Eur Radiol. 2020 Jan;30(1):186-194. doi: 10.1007/s00330-019-06351-0. Epub 2019 Aug 1.

PMID:
31372783
3.

Diagnostic accuracy of imaging studies for initial staging of T2b to T4b melanoma patients: A cross-sectional study.

Riquelme-Mc Loughlin C, Podlipnik S, Bosch-Amate X, Riera-Monroig J, Barreiro A, Espinosa N, Moreno-Ramírez D, Giavedoni P, Vilana R, Sánchez M, Vidal-Sicart S, Carrera C, Malvehy J, Puig S.

J Am Acad Dermatol. 2019 Dec;81(6):1330-1338. doi: 10.1016/j.jaad.2019.05.076. Epub 2019 Jun 1.

PMID:
31163236
4.

Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis.

Ayuso C, Forner A, Darnell A, Rimola J, García-Criado Á, Bianchi L, Vilana R, Oliveira R, Llarch N, Bruix J.

Liver Int. 2019 Jul;39(7):1281-1291. doi: 10.1111/liv.14133. Epub 2019 May 28.

PMID:
31077539
5.

Corrigendum to "Diagnosis and staging of hepatocellular carcinoma (HCC): Current guidelines" [Eur. J. Radiol. 101 (2018) 72-81].

Ayuso C, Rimola J, Vilana R, Burrel M, Darnell A, García-Criado Á, Bianchi L, Belmonte E, Caparroz C, Barrufet M, Bruix J, Brú C.

Eur J Radiol. 2019 Mar;112:229. doi: 10.1016/j.ejrad.2019.01.018. Epub 2019 Jan 30. No abstract available.

PMID:
30709654
6.

Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules.

Mariño Z, Darnell A, Lens S, Sapena V, Díaz A, Belmonte E, Perelló C, Calleja JL, Varela M, Rodriguez M, Rodriguez de Lope C, Llerena S, Torras X, Gallego A, Sala M, Morillas RM, Minguez B, Llaneras J, Coll S, Carrion JA, Iñarrairaegui M, Sangro B, Vilana R, Sole M, Ayuso C, Ríos J, Forns X, Bruix J, Reig M.

J Hepatol. 2019 May;70(5):874-884. doi: 10.1016/j.jhep.2019.01.005. Epub 2019 Jan 24.

PMID:
30684506
7.

Role of Kupffer cells in the progression of CRC liver metastases after the first stage of ALPPS.

García-Pérez R, Ferrer Fábrega J, Varona-Bosque A, Martínez CM, Revilla-Nuin B, Cabellos L, Pena R, Vilana R, Gonzalez-Abós C, García-Valdecasas JC, Fuster Obregón J.

Sci Rep. 2018 May 24;8(1):8089. doi: 10.1038/s41598-018-26082-4.

8.

Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines.

Ayuso C, Rimola J, Vilana R, Burrel M, Darnell A, García-Criado Á, Bianchi L, Belmonte E, Caparroz C, Barrufet M, Bruix J, Brú C.

Eur J Radiol. 2018 Apr;101:72-81. doi: 10.1016/j.ejrad.2018.01.025. Epub 2018 Jan 31. Review. Erratum in: Eur J Radiol. 2019 Mar;112:229.

PMID:
29571804
9.

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians.

Carrera C, Gual A, Díaz A, Puig-Butillé JA, Noguès S, Vilalta A, Conill C, Rull R, Vilana R, Arguis P, Vidal-Sicart S, Alós L, Palou J, Castel T, Malvehy J, Puig S.

Melanoma Res. 2017 Aug;27(4):315-320. doi: 10.1097/CMR.0000000000000340.

PMID:
28296711
10.

Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients.

Caballero-Baños M, Benitez-Ribas D, Tabera J, Varea S, Vilana R, Bianchi L, Ayuso JR, Pagés M, Carrera G, Cuatrecasas M, Martin-Richard M, Cid J, Lozano M, Castells A, García-Albéniz X, Maurel J, Vilella R.

Eur J Cancer. 2016 Sep;64:167-74. doi: 10.1016/j.ejca.2016.06.008. Epub 2016 Jul 16.

PMID:
27428073
11.

Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study.

Podlipnik S, Carrera C, Sánchez M, Arguis P, Olondo ML, Vilana R, Rull R, Vidal-Sicart S, Vilalta A, Conill C, Malvehy J, Puig S.

J Am Acad Dermatol. 2016 Sep;75(3):516-524. doi: 10.1016/j.jaad.2016.02.1229. Epub 2016 May 13.

PMID:
27183845
12.

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.

Reig M, Mariño Z, Perelló C, Iñarrairaegui M, Ribeiro A, Lens S, Díaz A, Vilana R, Darnell A, Varela M, Sangro B, Calleja JL, Forns X, Bruix J.

J Hepatol. 2016 Oct;65(4):719-726. doi: 10.1016/j.jhep.2016.04.008. Epub 2016 Apr 13.

PMID:
27084592
13.

Reply to: ''Poor contrast enhanced ultrasonography! There is no limit to its decline in the diagnosis of hepatocellular carcinoma on cirrhosis!''.

Forner A, Vilana R, Solé M, Bruix J.

J Hepatol. 2015 Jun;62(6):1453-4. doi: 10.1016/j.jhep.2015.02.016. Epub 2015 Feb 19. No abstract available.

14.

Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience.

de la Serna S, Vilana R, Sánchez-Cabús S, Calatayud D, Ferrer J, Molina V, Fondevila C, Bruix J, Fuster J, García-Valdecasas JC.

HPB (Oxford). 2015 May;17(5):387-93. doi: 10.1111/hpb.12379. Epub 2014 Dec 29.

15.

Prognosis prediction and staging.

Forner A, Díaz-González A, Liccioni A, Vilana R.

Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):855-65. doi: 10.1016/j.bpg.2014.08.002. Epub 2014 Aug 23. Review.

PMID:
25260313
16.

Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.

Forner A, Vilana R, Bianchi L, Rodríguez-Lope C, Reig M, García-Criado MÁ, Rimola J, Solé M, Ayuso C, Bru C, Bruix J.

J Hepatol. 2015 Jan;62(1):150-5. doi: 10.1016/j.jhep.2014.08.028. Epub 2014 Aug 27.

PMID:
25173969
17.

Impact of contrast-enhanced ultrasound in the study of hepatic artery hypoperfusion shortly after liver transplantation: contribution to the diagnosis of artery steal syndrome.

García-Criado A, Gilabert R, Bianchi L, Vilana R, Burrel M, Barrufet M, Oliveira R, García-Valdecasas JC, Brú C.

Eur Radiol. 2015 Jan;25(1):196-202. doi: 10.1007/s00330-014-3377-5. Epub 2014 Aug 12.

PMID:
25117745
18.

Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI.

Rimola J, Forner A, Tremosini S, Reig M, Vilana R, Bianchi L, Rodríguez-Lope C, Solé M, Ayuso C, Bruix J.

J Hepatol. 2012 Jun;56(6):1317-23. doi: 10.1016/j.jhep.2012.01.004. Epub 2012 Feb 4.

PMID:
22314420
19.

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.

Tremosini S, Forner A, Boix L, Vilana R, Bianchi L, Reig M, Rimola J, Rodríguez-Lope C, Ayuso C, Solé M, Bruix J.

Gut. 2012 Oct;61(10):1481-7. doi: 10.1136/gutjnl-2011-301862. Epub 2012 Jan 27.

PMID:
22287594
20.

Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques.

Bruix J, Reig M, Rimola J, Forner A, Burrel M, Vilana R, Ayuso C.

Hepatology. 2011 Dec;54(6):2238-44. doi: 10.1002/hep.24670. Review. No abstract available.

PMID:
21932394
21.

Assessment of radiofrequency ablation of lung metastasis from colorectal cancer using dual time-point PET/CT.

Lafuente S, Arguis P, Fuster D, Vilana R, Lomeña F, Pons F.

Clin Nucl Med. 2011 Jul;36(7):603-5. doi: 10.1097/RLU.0b013e318217741b.

PMID:
21637074
22.

[Imaging diagnosis of hepatocellular carcinoma. Addendum to hepatocellular carcinoma: diagnosis, staging and treatment strategies].

Vilana R, Forner A, García A, Ayuso C, Bru C.

Radiologia. 2011 Mar-Apr;53(2):156-8. doi: 10.1016/j.rx.2010.10.005. Epub 2011 Mar 29. Spanish.

23.

[Percutaneous and intra-arterial treatment of hepatocellular carcinoma].

Real MI, Bianchi L, Vilana R, Burrel M, Rimola J.

Radiologia. 2010 Sep-Oct;52(5):399-413. doi: 10.1016/j.rx.2010.05.002. Review. Spanish.

24.

[Hepatocellular carcinoma: diagnosis, staging, and treatment strategy].

Vilana R, Forner A, García A, Ayuso C, Bru C.

Radiologia. 2010 Sep-Oct;52(5):385-98. doi: 10.1016/j.rx.2010.05.003. Epub 2010 Jul 27. Spanish.

25.

Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.

Vilana R, Forner A, Bianchi L, García-Criado A, Rimola J, de Lope CR, Reig M, Ayuso C, Brú C, Bruix J.

Hepatology. 2010 Jun;51(6):2020-9. doi: 10.1002/hep.23600.

PMID:
20512990
26.

Percutaneous ethanol injection before liver transplantation in the hepatocellular carcinoma.

Branco F, Brú C, Vilana R, Bianchi L, Alves de Mattos A.

Ann Hepatol. 2009 Jul-Sep;8(3):220-7.

27.

Preoperative assessment of cutaneous melanoma thickness using 10-MHz sonography.

Vilana R, Puig S, Sanchez M, Squarcia M, Lopez A, Castel T, Malvehy J.

AJR Am J Roentgenol. 2009 Sep;193(3):639-43. doi: 10.2214/AJR.08.1387.

PMID:
19696275
28.

Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.

Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, Bruix J.

Hepatology. 2009 Sep;50(3):791-8. doi: 10.1002/hep.23071.

PMID:
19610049
29.
30.

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, Brú C, Bruix J.

Hepatology. 2008 Jan;47(1):97-104. Erratum in: Hepatology. 2008 Feb;47(2):769.

PMID:
18069697
31.

Tuberculous epididymo-orchitis after intravesical BCG therapy for superficial bladder carcinoma: sonographic findings.

Salvador R, Vilana R, Bargalló X, Araque X, Nicolau C.

J Ultrasound Med. 2007 May;26(5):671-4. No abstract available.

PMID:
17460010
32.

[Melanoma metastasis to the gallbladder].

Romero M, Bianchi L, Vilana R.

Radiologia. 2006 Sep-Oct;48(5):321-3. Review. Spanish.

33.

Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography.

Catala V, Nicolau C, Vilana R, Pages M, Bianchi L, Sanchez M, Bru C.

Eur Radiol. 2007 Apr;17(4):1066-73. Epub 2006 Oct 27.

PMID:
17072617
34.

New aspects of diagnosis and therapy of hepatocellular carcinoma.

Bruix J, Hessheimer AJ, Forner A, Boix L, Vilana R, Llovet JM.

Oncogene. 2006 Jun 26;25(27):3848-56. Review.

PMID:
16799626
35.

Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?

Vilana R, Bianchi L, Varela M, Nicolau C, Sánchez M, Ayuso C, García M, Sala M, Llovet JM, Bruix J, Bru C; BCLC Group.

Eur Radiol. 2006 Nov;16(11):2454-62. Epub 2006 May 18.

PMID:
16710666
36.

Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions.

Nicolau C, Vilana R, Catalá V, Bianchi L, Gilabert R, García A, Brú C.

AJR Am J Roentgenol. 2006 Jan;186(1):158-67.

PMID:
16357396
37.

The use of contrast-enhanced ultrasound in the management of the cirrhotic patient and for detection of HCC.

Nicolau C, Vilana R, Brú C.

Eur Radiol. 2004 Oct;14 Suppl 8:P63-71.

PMID:
15700334
38.

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

Sala M, Llovet JM, Vilana R, Bianchi L, Solé M, Ayuso C, Brú C, Bruix J; Barcelona Clínic Liver Cancer Group.

Hepatology. 2004 Dec;40(6):1352-60.

PMID:
15565564
39.

Abdominal drainage after liver resection for hepatocellular carcinoma in cirrhotic patients: a randomized controlled study.

Fuster J, Llovet JM, Garcia-Valdecasas JC, Grande L, Fondevila C, Vilana R, Palacin J, Tabet J, Ferrer J, Bruix J, Visa J.

Hepatogastroenterology. 2004 Mar-Apr;51(56):536-40.

PMID:
15086197
40.

Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation.

Nicolau C, Catalá V, Vilana R, Gilabert R, Bianchi L, Solé M, Pagés M, Brú C.

Eur Radiol. 2004 Jun;14(6):1092-9. Epub 2004 Mar 9.

PMID:
15007620
41.

Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate.

Vilella R, Benítez D, Milà J, Lozano M, Vilana R, Pomes J, Tomas X, Costa J, Vilalta A, Malvehy J, Puig S, Mellado B, Martí R, Castel T.

Cancer Immunol Immunother. 2004 Jul;53(7):651-8. Epub 2004 Mar 16.

PMID:
14999431
42.

Significance of and contributing factors for a high resistive index on Doppler sonography of the hepatic artery immediately after surgery: prognostic implications for liver transplant recipients.

García-Criado A, Gilabert R, Salmerón JM, Nicolau C, Vilana R, Bianchi L, Buñesch L, García-Valdecasas JC, Rimola A, Brú C.

AJR Am J Roentgenol. 2003 Sep;181(3):831-8.

PMID:
12933490
43.

Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications.

Horcajada JP, Vilana R, Moreno-Martínez A, Alvarez-Vijande R, Bru C, Bargalló X, Buñesch L, Martínez JA, Mensa J.

Scand J Infect Dis. 2003;35(2):114-20.

PMID:
12693562
44.

Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.

Vilana R, Llovet JM, Bianchi L, Sanchez M, Pagés M, Sala M, Gilabert R, Nicolau C, Garcia A, Ayuso C, Bruix J, Bru C; Barcelona Clinic Liver Cancer Group.

J Clin Ultrasound. 2003 Mar-Apr;31(3):119-28.

PMID:
12594796
45.

[Evaluation of the efficacy and efficiency of a multidisciplinary unit for the treatment of patients with colorectal cancer].

Soriano A, Castells A, Lacy AM, Ayuso C, Ayuso JR, Conill C, Delgado S, Fuster J, García-Valdecasas JC, Ginès A, Martín M, Maurel J, Miquel R, Mollà M, Vilana R, Castellví-Bel S, Elizalde JI, Piñol V, Pellisé M, Biete A, Gascón P, Piqué JM.

Gastroenterol Hepatol. 2002 Dec;25(10):579-84. Spanish.

PMID:
12459118
46.

Accuracy of sonography with a hydration test in differentiating between excretory renal obstruction and renal sinus cysts.

Nicolau C, Vilana R, Del Amo M, Anguera A, Sala X, Pages M, Arguis P, Brú C.

J Clin Ultrasound. 2002 Nov-Dec;30(9):532-6.

PMID:
12404518
47.

Gray-scale ultrasound in hepatic cirrhosis and chronic hepatitis: diagnosis, screening, and intervention.

Nicolau C, Bianchi L, Vilana R.

Semin Ultrasound CT MR. 2002 Feb;23(1):3-18. Review.

PMID:
11866221
48.

Constrictive penile band injury: color Doppler sonographic assessment.

Bargalló X, Buñesch L, de Juan C, Vilana R, Brú C.

J Ultrasound Med. 2002 Feb;21(2):215-7. No abstract available.

PMID:
11833879
49.

[Radiofrequency in the treatment of hepatocellular carcinoma].

Llovet JM, Vilana R, Bianchi L, Brú C.

Gastroenterol Hepatol. 2001 Jun-Jul;24(6):303-11. Review. Spanish. No abstract available.

PMID:
11459568
50.

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

Llovet JM, Vilana R, Brú C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pagès M, Ayuso C, Solé M, Rodés J, Bruix J; Barcelona Clínic Liver Cancer (BCLC) Group.

Hepatology. 2001 May;33(5):1124-9.

PMID:
11343240

Supplemental Content

Loading ...
Support Center